FDA Approves 2nd Gene Therapy

THURSDAY, Oct. 19, 2017 (HealthDay News) — The U.S. Food and Drug Administration has approved the second gene therapy for use in the United States. The new treatment, Yescarta (axicabtagene ciloleucel), is for a kind of blood cancer called large B-cell lymphoma. The treatment is known as chimeric antigen receptor (CAR) T cell therapy, and…

Details

HPV Vaccine Safe for Adult Women: Study

WEDNESDAY, Oct. 18, 2017 (HealthDay News) — Vaccines that ward off the cancer-linked human papillomavirus (HPV) are safe for adult women, according to a study of more than 3 million Scandinavians. The researchers, who used Danish and Swedish hospital data to track the incidence of 44 different illnesses over 10 years, found no “serious safety…

Details